HOB Biotech Group Corp

HOB Biotech Group Corp EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of HOB Biotech Group Corp (688656.SS) as of Oct 17, 2026 is 26.83 M CNY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 59.52 M CNY — a change of -54.92% (lower).

EBITDA

26.83 MCNY

YoY

-54.92%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of HOB Biotech Group Corp is 2025 26.83 M CNY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of HOB Biotech Group Corp was 2024 59.52 M CNY. It decreases by -54.92% lower compared to the previous year.

The HOB Biotech Group Corp EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
51.26 M CNY
Jan 1, 2019
74.07 M CNY
Jan 1, 2020
69.97 M CNY
Jan 1, 2021
104.71 M CNY
Jan 1, 2022
58.96 M CNY
Jan 1, 2023
69.87 M CNY
Jan 1, 2024
59.52 M CNY
Jan 1, 2025
26.83 M CNY
The HOB Biotech Group Corp EBITDA history
YEAREBITDAYoY
26.83 MCNY-54.92%
59.52 MCNY-14.81%
69.87 MCNY+18.49%
58.96 MCNY-43.69%
104.71 MCNY+49.64%
69.97 MCNY-5.54%
74.07 MCNY+44.50%
51.26 MCNY+92.09%
26.69 MCNY+748.22%
3.15 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

HOB Biotech Group Corp Stock analysis

What does HOB Biotech Group Corp do? HOB Biotech Group Corp Ltd, based in Suzhou, China, operates in the Health Care sector, specializing in biotechnology. The company develops, produces, and sells in-vitro diagnostic reagents, offering allergy testing products under brands like Oboke and Fubok, and self-immune testing products such as Norbok and Nabok. Utilizing techniques including enzyme-linked immunosorbent assays and nano-magnetic particle chemiluminescence, it serves the domestic market with 488 employees and was listed on 13 January 2021. HOB Biotech Group Corp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about HOB Biotech Group Corp stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of HOB Biotech Group Corp is 26.83 M CNY in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of HOB Biotech Group Corp changed from 59.52 M CNY to 26.83 M CNY, representing a -54.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) HOB Biotech Group Corp since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s HOB Biotech Group Corp historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — HOB Biotech Group Corp

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — HOB Biotech Group Corp